HomeProductsBioactive CompoundsCell CycleCDKDalpiciclib
Chemical structure of CAS 1637781-04-4

Dalpiciclib

In Stock•Starting at $32 for 5 mg•Purity ≥ 99%
CAS No.1637781-04-4
MDL No.N/A
MFC25H30N6O2
MW446.50
InChI KeySGJLSPUSUBJWHO-UHFFFAOYSA-N

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
5 mg99%$32In Stock
50 mg99%$139In Stock
100 mg99%$236In Stock
250 mg99%$461In Stock
Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.1637781-04-4
Product NameDalpiciclib

Associated Conditions

neoplasm·head and neck squamous cell carcinoma·sarcoma·ovarian carcinoma·liver disease·
* The information provided here is compiled from public sources and is for reference only.

Related Articles

Studies related to this compound and its mechanism of action

Preclinical characterization of SHR6390, a novel CDK 4/6 inhibitor, in vitro and in human tumor xenograft models.

Cancer science • Vol. 110, Issue 4 • 2019
PMID: 30724426PMC: PMC6447953DOI: 10.1111/cas.13957

CDK4/6 inhibitor-SHR6390 exerts potent antitumor activity in esophageal squamous cell carcinoma by inhibiting phosphorylated Rb and inducing G1 cell cycle arrest.

Journal of translational medicine • Vol. 15, Issue 1 • 2017
PMID: 28578693PMC: PMC5457542DOI: 10.1186/s12967-017-1231-7

Documentation

Similar Products